Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GFP Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global GFP Antibody Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Western Blot
1.3.3 Immunohistochemistry
1.3.4 Immunocytochemistry
1.3.5 Immunofluorescence
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GFP Antibody Market Perspective (2018-2029)
2.2 GFP Antibody Growth Trends by Region
2.2.1 Global GFP Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 GFP Antibody Historic Market Size by Region (2018-2024)
2.2.3 GFP Antibody Forecasted Market Size by Region (2024-2029)
2.3 GFP Antibody Market Dynamics
2.3.1 GFP Antibody Industry Trends
2.3.2 GFP Antibody Market Drivers
2.3.3 GFP Antibody Market Challenges
2.3.4 GFP Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GFP Antibody Players by Revenue
3.1.1 Global Top GFP Antibody Players by Revenue (2018-2024)
3.1.2 Global GFP Antibody Revenue Market Share by Players (2018-2024)
3.2 Global GFP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GFP Antibody Revenue
3.4 Global GFP Antibody Market Concentration Ratio
3.4.1 Global GFP Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GFP Antibody Revenue in 2022
3.5 GFP Antibody Key Players Head office and Area Served
3.6 Key Players GFP Antibody Product Solution and Service
3.7 Date of Enter into GFP Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GFP Antibody Breakdown Data by Type
4.1 Global GFP Antibody Historic Market Size by Type (2018-2024)
4.2 Global GFP Antibody Forecasted Market Size by Type (2024-2029)
5 GFP Antibody Breakdown Data by Application
5.1 Global GFP Antibody Historic Market Size by Application (2018-2024)
5.2 Global GFP Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America GFP Antibody Market Size (2018-2029)
6.2 North America GFP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America GFP Antibody Market Size by Country (2018-2024)
6.4 North America GFP Antibody Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GFP Antibody Market Size (2018-2029)
7.2 Europe GFP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe GFP Antibody Market Size by Country (2018-2024)
7.4 Europe GFP Antibody Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GFP Antibody Market Size (2018-2029)
8.2 Asia-Pacific GFP Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific GFP Antibody Market Size by Region (2018-2024)
8.4 Asia-Pacific GFP Antibody Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GFP Antibody Market Size (2018-2029)
9.2 Latin America GFP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America GFP Antibody Market Size by Country (2018-2024)
9.4 Latin America GFP Antibody Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GFP Antibody Market Size (2018-2029)
10.2 Middle East & Africa GFP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa GFP Antibody Market Size by Country (2018-2024)
10.4 Middle East & Africa GFP Antibody Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific GFP Antibody Introduction
11.1.4 Thermo Fisher Scientific Revenue in GFP Antibody Business (2018-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Aviva Systems Biology
11.2.1 Aviva Systems Biology Company Detail
11.2.2 Aviva Systems Biology Business Overview
11.2.3 Aviva Systems Biology GFP Antibody Introduction
11.2.4 Aviva Systems Biology Revenue in GFP Antibody Business (2018-2024)
11.2.5 Aviva Systems Biology Recent Development
11.3 Santa Cruz Biotechnology
11.3.1 Santa Cruz Biotechnology Company Detail
11.3.2 Santa Cruz Biotechnology Business Overview
11.3.3 Santa Cruz Biotechnology GFP Antibody Introduction
11.3.4 Santa Cruz Biotechnology Revenue in GFP Antibody Business (2018-2024)
11.3.5 Santa Cruz Biotechnology Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Detail
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec GFP Antibody Introduction
11.4.4 Miltenyi Biotec Revenue in GFP Antibody Business (2018-2024)
11.4.5 Miltenyi Biotec Recent Development
11.5 Proteintech
11.5.1 Proteintech Company Detail
11.5.2 Proteintech Business Overview
11.5.3 Proteintech GFP Antibody Introduction
11.5.4 Proteintech Revenue in GFP Antibody Business (2018-2024)
11.5.5 Proteintech Recent Development
11.6 Synaptic Systems
11.6.1 Synaptic Systems Company Detail
11.6.2 Synaptic Systems Business Overview
11.6.3 Synaptic Systems GFP Antibody Introduction
11.6.4 Synaptic Systems Revenue in GFP Antibody Business (2018-2024)
11.6.5 Synaptic Systems Recent Development
11.7 NSJ Bioreagents
11.7.1 NSJ Bioreagents Company Detail
11.7.2 NSJ Bioreagents Business Overview
11.7.3 NSJ Bioreagents GFP Antibody Introduction
11.7.4 NSJ Bioreagents Revenue in GFP Antibody Business (2018-2024)
11.7.5 NSJ Bioreagents Recent Development
11.8 Medimabs
11.8.1 Medimabs Company Detail
11.8.2 Medimabs Business Overview
11.8.3 Medimabs GFP Antibody Introduction
11.8.4 Medimabs Revenue in GFP Antibody Business (2018-2024)
11.8.5 Medimabs Recent Development
11.9 EXBIO
11.9.1 EXBIO Company Detail
11.9.2 EXBIO Business Overview
11.9.3 EXBIO GFP Antibody Introduction
11.9.4 EXBIO Revenue in GFP Antibody Business (2018-2024)
11.9.5 EXBIO Recent Development
11.10 Bio X Cell
11.10.1 Bio X Cell Company Detail
11.10.2 Bio X Cell Business Overview
11.10.3 Bio X Cell GFP Antibody Introduction
11.10.4 Bio X Cell Revenue in GFP Antibody Business (2018-2024)
11.10.5 Bio X Cell Recent Development
11.11 ProSci
11.11.1 ProSci Company Detail
11.11.2 ProSci Business Overview
11.11.3 ProSci GFP Antibody Introduction
11.11.4 ProSci Revenue in GFP Antibody Business (2018-2024)
11.11.5 ProSci Recent Development
11.12 United States Biological
11.12.1 United States Biological Company Detail
11.12.2 United States Biological Business Overview
11.12.3 United States Biological GFP Antibody Introduction
11.12.4 United States Biological Revenue in GFP Antibody Business (2018-2024)
11.12.5 United States Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global GFP Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global GFP Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global GFP Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global GFP Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global GFP Antibody Market Share by Region (2018-2024)
Table 8. Global GFP Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global GFP Antibody Market Share by Region (2024-2029)
Table 10. GFP Antibody Market Trends
Table 11. GFP Antibody Market Drivers
Table 12. GFP Antibody Market Challenges
Table 13. GFP Antibody Market Restraints
Table 14. Global GFP Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global GFP Antibody Market Share by Players (2018-2024)
Table 16. Global Top GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFP Antibody as of 2022)
Table 17. Ranking of Global Top GFP Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by GFP Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players GFP Antibody Product Solution and Service
Table 21. Date of Enter into GFP Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global GFP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global GFP Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global GFP Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global GFP Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global GFP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global GFP Antibody Revenue Market Share by Application (2018-2024)
Table 29. Global GFP Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global GFP Antibody Revenue Market Share by Application (2024-2029)
Table 31. North America GFP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America GFP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America GFP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe GFP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe GFP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe GFP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific GFP Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific GFP Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific GFP Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America GFP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America GFP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America GFP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa GFP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa GFP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa GFP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Detail
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific GFP Antibody Product
Table 49. Thermo Fisher Scientific Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. Aviva Systems Biology Company Detail
Table 52. Aviva Systems Biology Business Overview
Table 53. Aviva Systems Biology GFP Antibody Product
Table 54. Aviva Systems Biology Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 55. Aviva Systems Biology Recent Development
Table 56. Santa Cruz Biotechnology Company Detail
Table 57. Santa Cruz Biotechnology Business Overview
Table 58. Santa Cruz Biotechnology GFP Antibody Product
Table 59. Santa Cruz Biotechnology Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 60. Santa Cruz Biotechnology Recent Development
Table 61. Miltenyi Biotec Company Detail
Table 62. Miltenyi Biotec Business Overview
Table 63. Miltenyi Biotec GFP Antibody Product
Table 64. Miltenyi Biotec Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 65. Miltenyi Biotec Recent Development
Table 66. Proteintech Company Detail
Table 67. Proteintech Business Overview
Table 68. Proteintech GFP Antibody Product
Table 69. Proteintech Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 70. Proteintech Recent Development
Table 71. Synaptic Systems Company Detail
Table 72. Synaptic Systems Business Overview
Table 73. Synaptic Systems GFP Antibody Product
Table 74. Synaptic Systems Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 75. Synaptic Systems Recent Development
Table 76. NSJ Bioreagents Company Detail
Table 77. NSJ Bioreagents Business Overview
Table 78. NSJ Bioreagents GFP Antibody Product
Table 79. NSJ Bioreagents Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 80. NSJ Bioreagents Recent Development
Table 81. Medimabs Company Detail
Table 82. Medimabs Business Overview
Table 83. Medimabs GFP Antibody Product
Table 84. Medimabs Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 85. Medimabs Recent Development
Table 86. EXBIO Company Detail
Table 87. EXBIO Business Overview
Table 88. EXBIO GFP Antibody Product
Table 89. EXBIO Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 90. EXBIO Recent Development
Table 91. Bio X Cell Company Detail
Table 92. Bio X Cell Business Overview
Table 93. Bio X Cell GFP Antibody Product
Table 94. Bio X Cell Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 95. Bio X Cell Recent Development
Table 96. ProSci Company Detail
Table 97. ProSci Business Overview
Table 98. ProSci GFP Antibody Product
Table 99. ProSci Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 100. ProSci Recent Development
Table 101. United States Biological Company Detail
Table 102. United States Biological Business Overview
Table 103. United States Biological GFP Antibody Product
Table 104. United States Biological Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 105. United States Biological Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GFP Antibody Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global GFP Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global GFP Antibody Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global GFP Antibody Market Share by Application: 2022 VS 2029
Figure 7. Western Blot Case Studies
Figure 8. Immunohistochemistry Case Studies
Figure 9. Immunocytochemistry Case Studies
Figure 10. Immunofluorescence Case Studies
Figure 11. Others Case Studies
Figure 12. GFP Antibody Report Years Considered
Figure 13. Global GFP Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global GFP Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global GFP Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global GFP Antibody Market Share by Players in 2022
Figure 17. Global Top GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFP Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by GFP Antibody Revenue in 2022
Figure 19. North America GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America GFP Antibody Market Share by Country (2018-2029)
Figure 21. United States GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe GFP Antibody Market Share by Country (2018-2029)
Figure 25. Germany GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific GFP Antibody Market Share by Region (2018-2029)
Figure 33. China GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America GFP Antibody Market Share by Country (2018-2029)
Figure 41. Mexico GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa GFP Antibody Market Share by Country (2018-2029)
Figure 45. Turkey GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 48. Aviva Systems Biology Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 49. Santa Cruz Biotechnology Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 50. Miltenyi Biotec Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 51. Proteintech Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 52. Synaptic Systems Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 53. NSJ Bioreagents Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 54. Medimabs Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 55. EXBIO Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 56. Bio X Cell Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 57. ProSci Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 58. United States Biological Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed